
Writer
Sravani Pamanji
PharmD
Sravani Pamanji is a PharmD professional with experience in scientific writing, medical literature review, drug profile preparation, and clinical case documentation. She has contributed to scientific publication and presented at the 74th Indian Pharmaceutical Congress. Her training includes ICH GCP E6(R3), scientific research, and medication safety. She is passionate about evidence-based medical communication and accurate dissemination of clinical and pharmaceutical information.
22
Articles written or reviewed
About Sravani
Sravani Pamanji (PharmD) is a writer at Pharmacally, with 22 published articles, each checked against primary sources by our editorial team.
Writes about
On Pharmacally
Articles by Sravani Pamanji
Clinical TrialsPharvaris Adds Long-Term HAE Prophylaxis and On-Demand Data for Deucrictibant
Clinical TrialsBeam Reports Positive BEACON Results for Risto-cel in SCD
Clinical TrialsAlnylam Highlights 5-Year Cardiovascular Benefits of Vutrisiran
Health TidingsKaliVir Reports 71% Response Rate With VET3-TGI in Skin Cancers
Health TidingsResolution Reports 42% Lower Clinical Event Risk in ESLD, Advances RTX001 Towards US Pivotal Trial
Clinical TrialsAgenus Reports 36% Major Response With BOT+BAL in Colon Cancer
Health TidingsNeuren Secures FDA Orphan Drug Status for NNZ-2591 in HIE
Clinical TrialsBioNTech and DualityBio Report Modest PFS Gain but Higher ILD in Breast Cancer Trial
Clinical TrialsArtiva Ends AlloNK Development After Durability Shortfall and Two Fatal EventsOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala